Other Deals - Listed Firms
Cohance Lifesciences promoter sells 8.9% stake for Rs.3,094-Cr in bulk deal
Promoter Jusmiral Holdings has offloaded an 8.9% stake (3.41 lakh shares) in Hyderabad-based Cohance Lifesciences , a contract development and manufacturing organisation, for INR 3,093.8 crore (at INR 906 per share) via open market transactions on September 18. The promoters' shareholding in the company was 66.41% as of June 2025.HDFC Mutual Fund and SBI Mutual Fund acquired some of those Cohance shares, buying 37.17 lakh shares (0.97% stake) at INR 906 per share, amounting to INR 336.8 crore, and 26.83 lakh shares (0.7%) at INR 905.71 per share for INR 243 crore, respectively.Cohance Lifesciences is a Contract Development and Manufacturing Organization (CDMO) that provides integrated services for the development and manufacturing of New Chemical Entity (NCE)-based intermediates, Active Pharmaceutical Ingredients (APIs), specialty chemicals, and formulations for global pharmaceutical, biotechnology, and chemical companies.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
